New eye drug shows promise in early safety trial for blinding disease
Disease control
Completed
This early-stage study tested a new drug called PMC-403 in 17 people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The main goal was to check the drug's safety and find the best dose for future studies. Participants received the drug by injectio…
Phase: PHASE1 • Sponsor: PharmAbcine • Aim: Disease control
Last updated May 17, 2026 11:35 UTC